Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma

Stereotactic body radiotherapy (SBRT) is an advanced form of radiotherapy (RT) with a growing interest on its application in the treatment of hepatocellular carcinoma (HCC). It can deliver ablative radiation doses to tumors in a few fractions without excessive doses to normal tissues, with the help...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jongmoo, Park, Jae Won, Kang, Min Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yeungnam University College of Medicine 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784649/
https://www.ncbi.nlm.nih.gov/pubmed/31620633
http://dx.doi.org/10.12701/yujm.2019.00269
_version_ 1783457784785797120
author Park, Jongmoo
Park, Jae Won
Kang, Min Kyu
author_facet Park, Jongmoo
Park, Jae Won
Kang, Min Kyu
author_sort Park, Jongmoo
collection PubMed
description Stereotactic body radiotherapy (SBRT) is an advanced form of radiotherapy (RT) with a growing interest on its application in the treatment of hepatocellular carcinoma (HCC). It can deliver ablative radiation doses to tumors in a few fractions without excessive doses to normal tissues, with the help of advanced modern RT and imaging technologies. Currently, SBRT is recommended as an alternative to curative treatments, such as surgery and radiofrequency ablation. This review discusses the current status of SBRT to aid in the decision making on how it is incorporated into the HCC management.
format Online
Article
Text
id pubmed-6784649
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Yeungnam University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-67846492019-10-16 Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma Park, Jongmoo Park, Jae Won Kang, Min Kyu Yeungnam Univ J Med Review Article Stereotactic body radiotherapy (SBRT) is an advanced form of radiotherapy (RT) with a growing interest on its application in the treatment of hepatocellular carcinoma (HCC). It can deliver ablative radiation doses to tumors in a few fractions without excessive doses to normal tissues, with the help of advanced modern RT and imaging technologies. Currently, SBRT is recommended as an alternative to curative treatments, such as surgery and radiofrequency ablation. This review discusses the current status of SBRT to aid in the decision making on how it is incorporated into the HCC management. Yeungnam University College of Medicine 2019-08-12 /pmc/articles/PMC6784649/ /pubmed/31620633 http://dx.doi.org/10.12701/yujm.2019.00269 Text en Copyright © 2019 Yeungnam University College of Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Park, Jongmoo
Park, Jae Won
Kang, Min Kyu
Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
title Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
title_full Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
title_fullStr Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
title_full_unstemmed Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
title_short Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
title_sort current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784649/
https://www.ncbi.nlm.nih.gov/pubmed/31620633
http://dx.doi.org/10.12701/yujm.2019.00269
work_keys_str_mv AT parkjongmoo currentstatusofstereotacticbodyradiotherapyforthetreatmentofhepatocellularcarcinoma
AT parkjaewon currentstatusofstereotacticbodyradiotherapyforthetreatmentofhepatocellularcarcinoma
AT kangminkyu currentstatusofstereotacticbodyradiotherapyforthetreatmentofhepatocellularcarcinoma

Ejemplares similares